Class 4 Medicines Defect Information: Drugsrus Limited, Clexane 10,000 IU (100mg) / 1ml Syringes, EL(23)A/08
Drugsrus Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in specific batches of Clexane 10,000IU (100mg)/1 ml Syringes contains a typographical error in the leaflet.
MDR number
MDR 173-01/23
Company name
Drugsrus Limited & Star Pharmaceuticals Ltd & Tenolol Ltd
Product name
Clexane 10,000 IU (100mg) / 1ml Syringes (Star Pharmaceuticals Ltd), PLPI 20636/1822
SNOMED Code
36564011000001106
Batch No | Expiry Date | Pack Size | First Distributed |
---|---|---|---|
ECD95D | 04/2024 | 10 | 07/07/2022 |
Active Pharmaceutical Ingredient: enoxaparin sodium
Product name
Clexane 10,000 IU (100mg) / 1ml Syringes (Tenolol Ltd), PLPI 30900/1997
SNOMED Code
36564011000001106
Batch No | Expiry Date | Pack Size | First Distributed |
---|---|---|---|
ECI41A | 10/2024 | 10 | 07/07/2022 |
FCA45G | 12/2024 | 10 | 13/12/2022 |
Active Pharmaceutical Ingredient: enoxaparin sodium
Brief description of the problem
Drugsrus Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in specific batches of Clexane 10,000IU (100mg)/1 ml Syringes contains a typographical error in the leaflet. The strength of the product listed in the leaflet header states “100,000 IU (100mg) / 1ml” instead of “10,000 IU (100mg)/1ml”. The remainder of the packaging, including the outer packaging and information on the syringe itself details the correct strength of 10,000 IU (100mg)/1ml.
A common leaflet is used for all strengths and so this error also appears in the leaflet packaged with other strengths – 2,000 IU (20mg)/0.2ml, 4,000 IU (40mg)/0.4ml, 6,000 IU (60mg)/0.6ml and 8,000 IU (80mg)/0.8ml.
Please see example image below which highlights the typographical error, which is only present on the leaflet header.
Advice for healthcare professionals
There is no risk to product quality as a result of this issue, and the affected batches are not being recalled. Healthcare professionals are advised to tell patients about the error and reassure them they have the right dose of this medicine, when dispensing subsequent batches or in discussion with patients who may raise concerns, where appropriate.
Drugsrus Limited has confirmed that all future batches will contain the correct PIL. Upon request, Drugsrus Limited will post hard copies of the updated PIL to wholesalers and pharmacies so that any remaining stock in the dispensary can be supplemented with the correct PIL information (see contact details below).
Advice for patients
The Patient Information Leaflets included with these specific batches of Clexane 10,000 IU (100mg)/1ml Syringes have a typographical error. This error lists the strength as “100,000 IU (100mg)/1ml” instead of “10,000 IU (100mg)/1ml”. The correct strength is listed elsewhere on the packaging as 10,000 IU. Please continue to use the product as advised by your doctor and pharmacist. The strength and quality of the medicine itself is not impacted and this is a typographical error only.
A common Patient Information Leaflet is used for all strengths of Clexane. This means that this error also appears in the leaflet with the other strengths of Clexane – 2,000 IU (20mg)/0.2ml, 4,000 IU (40mg)/0.4ml, 6,000 IU (60mg)/0.6ml and 8,000 IU (80mg)/0.8ml.
As for all medicines, if you experience any adverse reactions, you should contact your doctor immediately. You can also report suspected adverse reactions via the MHRA Yellow Card scheme.
Further Information
For more information, medical information queries or replacement PIL enquiries, please contact: [email protected] or 020 8423 3800. For stock control queries, please contact: [email protected] or 020 8423 3800
Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.
Yours faithfully
Defective Medicines Report Centre
10 South Colonnade
Canary Wharf
London
E14 4PU
Telephone +44 (0)20 3080 6574
Download document